EK

Eshan Kiwalkar Nitin

Active Director Director DIN 08397968
DIN 08397968 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Eshan Kiwalkar Nitin

Data last updated:

Eshan Kiwalkar Nitin is a Director at Opus Pet Private Limited (since 2019). The company operates in Pharma. Opus Pet Private Limited reported revenue of ₹4.22 Cr (FY 2024).

DIN 08397968
Primary Designation Director
Industry Pharma
First Appointment 25 Mar 2019
Oldest Company Age 7 yrs
Largest company Opus Pet Private Limited · ₹4.22 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Opus Pet Private Limited U01100PN2019PTC182956
Director25 Mar 20192019₹4.22 Cr (FY 2024)Active

Board colleagues of Eshan Kiwalkar Nitin

NameDINCompanyDesignation
Karan Singh06632961Opus Pet Private LimitedDirector

Directorship timeline

Open interactive timeline →
Opus Pet Private Limited
Premium access

Shareholding and investment profile for Eshan Kiwalkar Nitin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eshan Kiwalkar Nitin

Eshan Kiwalkar Nitin currently holds 1 directorship: Opus Pet Private Limited (Director, since 25 Mar 2019, revenue ₹4.22 Cr (FY 2024)).

Eshan Kiwalkar Nitin was first appointed on 25 Mar 2019 as Director at Opus Pet Private Limited.

The current boards of Eshan Kiwalkar Nitin's companies include Karan Singh (Opus Pet Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available